Pain Therapeutics Inc. | Mutual Funds
Mutual Funds that own Pain Therapeutics Inc.
Vanguard Total Stock Market Index Fund
109,368
0.64%
0
0%
07/31/2018
Vanguard Extended Market Index Fund
59,259
0.35%
1,003
0%
07/31/2018
Fidelity Spartan Extended Market Index Fund
20,714
0.12%
0
0%
07/31/2018
DFA US Micro Cap Portfolio
19,288
0.11%
0
0%
04/30/2018
DFA US Targeted Value Portfolio
17,455
0.1%
0
0%
04/30/2018
iShares Micro Cap ETF
16,141
0.09%
0
0%
09/06/2018
Bridgeway Ultra Small Company Market Fund
15,765
0.09%
-25,000
0%
12/31/2017
Fidelity Nasdaq Composite Index
12,106
0.07%
0
0%
07/31/2018
Northern Small Cap Core Fund
11,381
0.07%
11,381
0%
03/31/2018
Vanguard Institutional Total Stock Market Index Fund
7,306
0.04%
0
0%
07/31/2018
| Address |
7801 North Capital of Texas Highway
Austin Texas 78731
United States
|
|
Employees
|
- |
| Website |
http://www.paintrials.com |
| Updated |
09/14/2018 |
| Pain Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of novel drugs. Its drug candidate includes REMOXY, which is a strong painkiller with a unique formulation designed to reduce potential risks of unintended use. The company was founded by Remi Barbier and Barry M. |
